Cargando…
Curcumin as a Holistic Treatment for Tau Pathology
Global forecasts for prevalence of Alzheimer’s Disease (AD) estimate that 152.8 million people will have dementia in 2050, a sharp rise from 57.4 million in 2019 (GBD 2019). This rise can be attributable to increases in population growth and aging, but in the absence of disease-modifying therapies i...
Autores principales: | Sivanantharajah, Lovesha, Mudher, Amritpal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160965/ https://www.ncbi.nlm.nih.gov/pubmed/35662729 http://dx.doi.org/10.3389/fphar.2022.903119 |
Ejemplares similares
-
Tau-mediated axonal degeneration is prevented by activation of the Wld(S) pathway
por: Stubbs, Katy, et al.
Publicado: (2023) -
Acquisition of a Leucine Zipper Motif as a Mechanism of Antimorphy for an Allele of the Drosophila Hox Gene Sex Combs Reduced
por: Sivanantharajah, Lovesha, et al.
Publicado: (2014) -
Microtubule stabilising peptides rescue tau phenotypes in-vivo
por: Quraishe, Shmma, et al.
Publicado: (2016) -
Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits
por: Chatterjee, Shreyasi, et al.
Publicado: (2018) -
Corrigendum: Microtubule stabilising peptides rescue tau phenotypes in-vivo
por: Quraishe, Shmma, et al.
Publicado: (2017)